ACAD ACADIA Pharmaceuticals Inc. - Common Stock
ACADIA Pharmaceuticals Inc. - Common Stock के बारे में विकिपीडिया से कंपनी का अवलोकन
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, California.
और पढ़ें
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, California.
Product development
Nuplazid, a drug developed by Acadia in the late 1990s, "was designed to stimulate a subset of the brain’s serotonin receptors, or the proteins that govern memory, cognition and learning." On April 29, 2016, the FDA approved Acadia's drug, Nuplazid, for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. Nuplazid is the trade name for Acadia's proprietary molecule, pimavanserin, a selective serotonin inverse agonist preferentially targeting 5-HT2a receptors. Acadia had partnered with Biovail in the late-stage clinical testing of the drug, which showed trial failures as of 2009.
Acadia is running multiple Phase 2 and Phase 3 trials with pimavanserin in several central nervous system conditions: dementia-related psychosis, major depressive disorder, schizophrenia inadequate response, and schizophrenia negative symptoms.
As of 1997, Acadia was among several companies that licensed compounds from Genzyme's small-molecule compound library.
In 2023, the FDA approved trofinetide (marketed as Daybue) for use in Rett syndrome.
History
Acadia started in 1993 as Receptor Technologies, based in Winooski, Vermont. In 1997, the company relocated all operations and management from Vermont to San Diego, California, as a strategic move to garner partnerships with other biotechnology companies. However, the company also had an office in Denmark, in which it received a crucial part of its early investments from BankInvest, under managing director Florian Schönharting, Kommunernes Pensionsforsikring A/S and Dansk Kapitalanlæg Aktieselskab as well as private investor Lars Christiansen. At the time, the company had fifty employees, fourteen of whom were in the Denmark office. The focus of the company in its early years was on genetic screens for receptors, aiming to accelerate early stage drug discovery.
The company planned to conduct an initial public offering (IPO) consisting of 31.6% of the company in 2001, with the intention of raising US$64 million and listing on the NASDAQ exchange under the symbol ACAD. At the time, Acadia and Allergan were collaborating on development of a treatment for glaucoma, and Allergan would retain a 6.3% ownership stake in Acadia after the IPO. However, the company's IPO, which ultimately took place in May 2004, did not fare as well as expected and netted only US$35 million. At the time, the company had five drugs in development and was running two in human trials. The company had a subsequent round of stock offering in May 2007 which raised US$102 million.
In September 2020, Acadia Pharmaceuticals acquired clinical-stage biotechnology company CerSci Therapeutics.
Corporate governance
In 2001, the company's chief executive officer at the time, Leonard R. Borrmann, left Acadia to lead Maret Pharmaceuticals. He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the beginning of 2016.
== References ==
स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗
ACAD स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा
ACAD स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें
10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान
मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?
लाभप्रदता सकल, परिचालन और शुद्ध मार्जिन; ROE, ROA, ROIC
वित्तीय स्वास्थ्य ऋण, तरलता, शोधन क्षमता — बैलेंस शीट की मजबूती
विकास राजस्व, EPS और शुद्ध आय वृद्धि: YoY, 3Y CAGR, 5Y CAGR
पूंजी दक्षता एसेट टर्नओवर, इन्वेंटरी टर्नओवर, प्राप्य टर्नओवर
ACAD विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड
- मजबूत खरीद 7 25.9%
- खरीदें 14 51.9%
- होल्ड 5 18.5%
- बेचें 1 3.7%
- मजबूत बिक्री 0 0.0%
12-महीने का मूल्य लक्ष्य
20 विश्लेषक · 2026-08-18Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि
| Period | EPS Actual | EPS अनुमान | आश्चर्य |
|---|---|---|---|
| 30 जून 2026 | $0.18 | $0.06 | 0.12% |
| 31 मार्च 2026 | $0.02 | $0.06 | -0.04% |
| 31 दिसमबर 2025 | $1.60 | $0.14 | 1.5% |
| 30 सितमबर 2025 | $0.42 | $0.15 | 0.27% |
| 30 जून 2025 | $0.16 | $0.14 | 0.02% |
| 31 मार्च 2025 | $0.11 | $0.11 | -0.00% |
सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी
| टिकर | मार्केट कैप | P/E | राजस्व YoY | शुद्ध मार्जिन | ROE | सकल मार्जिन |
|---|---|---|---|---|---|---|
| ACAD | $4.55B | 11.6 | 11.9% | 36.5% | 38.1% | — |
| DNTH | $1.78B | -9.8 | -67.3% | -7973.3% | -40.8% | — |
| ERAS | $1.06B | -8.5 | — | — | -35.7% | — |
| CAI | $7.62B | -8.4 | 97.0% | -8.4% | -13.2% | — |
| PTCT | $6.19B | 9.8 | 114.5% | 39.4% | -331.5% | — |
| TVTX | $3.47B | -131.8 | 110.5% | -5.2% | -34.6% | — |
| DYN | $3.23B | -5.6 | — | — | -57.8% | — |
| PBLS | — | — | — | — | — | — |
| CELC | $4.81B | -26.3 | — | — | -244.3% | — |
| RLAY | $1.47B | -5.3 | 53.4% | -1800.6% | -44.9% | — |
पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह
आय विवरण 16
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.07B | $958M | $726M | $517M | $484M | $442M | $339M | $224M | $125M | $17M | $61.0K | $120.0K | |
| Cost of Revenue | $89M | $82M | $42M | $10M | $19M | $10M | $11M | $12M | $9M | $3M | · | · | |
| Gross Profit | · | · | $685M | $507M | $473M | $432M | $328M | $211M | $116M | $14M | · | · | |
| R&D Expense | $329M | $303M | $352M | $362M | $239M | $319M | $240M | $187M | $149M | $99M | $74M | $61M | |
| SG&A Expense | $549M | $488M | $407M | $369M | $396M | $389M | $326M | $266M | $255M | $186M | $88M | $33M | |
| Operating Expenses | $967M | $727M | $800M | $741M | $655M | $728M | $586M | $471M | $417M | $290M | $165M | $93M | |
| Operating Income | $105M | $231M | $-73M | $-224M | $-170M | $-287M | $-247M | $-247M | $-292M | $-273M | $-165M | $-93M | |
| Other Non-op | $2M | $2M | $5M | $4M | $2M | $-997.0K | $997.0K | $-2M | · | · | · | · | |
| Pretax Income | $139M | $258M | $-51M | $-213M | $-168M | $-281M | $-234M | $-244M | $-288M | $-270M | $-164M | $-92M | |
| Income Tax | $-252M | $32M | $10M | $3M | $351.0K | $611.0K | $876.0K | $1M | $1M | $1M | $330.0K | $0 | |
| Net Income | $391M | $226M | $-61M | $-216M | $-168M | $-282M | $-235M | $-245M | $-289M | $-271M | $-164M | $-92M | |
| EPS (Basic) | $2.32 | $1.37 | $-0.37 | $-1.34 | $-1.05 | $-1.79 | · | · | · | · | · | · | |
| EPS (Diluted) | $2.30 | $1.36 | $-0.37 | $-1.34 | $-1.05 | $-1.79 | · | · | · | · | · | · | |
| Shares (Basic) | 168,356,000 | 165,717,000 | 163,819,000 | 161,683,000 | 160,493 | 157,331 | · | · | · | · | · | · | |
| Shares (Diluted) | 169,919,000 | 166,362,000 | 163,819,000 | 161,683,000 | 160,493 | 157,331 | · | · | · | · | · | · | |
| EBITDA | $105M | $231M | $-73M | $-224M | $-170M | $-287M | $-247M | $-247M | $-292M | $-273M | $-165M | $-93M |
बैलेंस शीट 25
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $178M | $320M | $189M | $115M | $147M | $326M | $190M | $135M | $69M | $164M | $102M | $62M | |
| Receivables | $121M | $99M | $98M | $62M | $64M | $48M | $36M | $26M | $17M | $6M | · | · | |
| Inventory | $111M | $92M | $40M | $12M | $14M | $10M | $6M | $4M | $5M | $4M | · | · | |
| Prepaid Expense | $60M | $56M | $39M | $21M | $24M | $26M | $19M | $21M | $8M | $8M | $2M | $1M | |
| Current Assets | $1.06B | $938M | $616M | $508M | $618M | $718M | $760M | $526M | $373M | $548M | $219M | $325M | |
| PP&E (Net) | $8M | $4M | $5M | $6M | $8M | $9M | $3M | $3M | $3M | $3M | $2M | $553.0K | |
| PP&E (Gross) | $17M | $14M | $14M | $14M | $14M | $13M | $9M | $8M | $7M | $6M | $5M | $3M | |
| Accum. Depreciation | $9M | $10M | $10M | $8M | $6M | $4M | $5M | $4M | $4M | $3M | $3M | $2M | |
| Intangibles | $109M | $120M | $65M | $0 | $0 | $1M | $3M | $4M | $6M | $7M | · | · | |
| Other Non-current Assets | $4M | $359.0K | $476.0K | $8M | $4M | $2M | $3M | $2M | $354.0K | $785.0K | $329.0K | $287.0K | |
| Total Assets | $1.56B | $1.19B | $749M | $588M | $700M | $783M | $783M | $540M | $385M | $561M | $222M | $325M | |
| Accounts Payable | $11M | $16M | $18M | $13M | $7M | $8M | $7M | $3M | $9M | $4M | $2M | $2M | |
| Accrued Liabilities | $266M | $379M | $237M | $113M | $89M | $97M | $68M | $56M | $40M | $36M | $20M | $14M | |
| Current Liabilities | $277M | $395M | $254M | $126M | $96M | $106M | $75M | $60M | $49M | $43M | $22M | $16M | |
| Capital Leases | $41M | $42M | $48M | $53M | $56M | $44M | $6M | · | · | · | · | · | |
| Deferred Tax | $11M | $11M | $12M | $13M | $14M | $13M | $3M | · | · | · | · | · | |
| Other Non-current Liabilities | $19M | $18M | $15M | $9M | $7M | $5M | $3M | $2M | · | · | · | · | |
| Total Liabilities | $337M | $455M | $317M | $187M | $159M | $156M | $84M | $61M | $49M | $43M | $22M | $16M | |
| Common Stock | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $15.0K | $14.0K | $12.0K | $12.0K | $10.0K | $10.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | $1.45B | $862M | $808M | |
| Retained Earnings | $-1.81B | $-2.20B | $-2.43B | $-2.37B | $-2.15B | $-1.99B | $-1.70B | $-1.47B | $-1.22B | $-934M | $-663M | $-498M | |
| AOCI | $1M | $292.0K | $24.0K | $-975.0K | $-192.0K | $36.0K | $297.0K | $-372.0K | $-399.0K | $106.0K | $11.0K | $-9.0K | |
| Stockholders' Equity | $1.23B | $733M | $432M | $400M | $541M | $627M | $699M | $479M | $335M | $518M | $200M | $309M | |
| Liabilities + Equity | $1.56B | $1.19B | $749M | $588M | $700M | $783M | $783M | $540M | $385M | $561M | $222M | $325M | |
| Shares Outstanding | 170,309,376 | 166,708,856 | 164,650,219 | 162,064,872 | 161,012,695 | 159,637,771 | 155,275,300 | 143,853,597 | 124,410,552 | 121,367,169 | 101,938,702 | 100,047,331 |
नकदी प्रवाह 13
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | $206.0K | |
| Stock-based Comp | $52M | $67M | $66M | $68M | $64M | $84M | $82M | $82M | $76M | $55M | $40M | $16M | |
| Deferred Tax | $-250M | $0 | $0 | $3M | $351.0K | · | · | · | · | · | · | · | |
| Amort. of Intangibles | $11M | $15M | $4M | $0 | $1M | $1M | $1M | $1M | $1M | $985.0K | $0 | $0 | |
| Operating Cash Flow | $110M | $158M | $17M | $-114M | $-126M | $-136M | $-151M | $-167M | $-218M | $-208M | $-122M | $-66M | |
| CapEx | $5M | $523.0K | $50.0K | $0 | $1M | $8M | $1M | $2M | $812.0K | $2M | $2M | $180.0K | |
| Investing Cash Flow | $-303M | $-31M | $32M | $73M | $-71M | $193M | $-166M | $-71M | $92M | $-262M | · | · | |
| Stock Issued | $50M | $7M | $25M | $8M | $18M | $81M | $372M | $307M | $31M | $519M | $15M | $204M | |
| Net Stock Activity | $50M | $7M | $25M | $8M | $18M | $81M | $372M | $307M | $31M | $519M | $15M | $204M | |
| Financing Cash Flow | $50M | $7M | $25M | $8M | $18M | $81M | $372M | $307M | $31M | $534M | · | · | |
| Net Change in Cash | $-143M | $134M | $74M | $-33M | $-179M | $137M | $55M | $68M | $-94M | $63M | $40M | $50M | |
| Taxes Paid | $25M | $20M | $6M | $2M | $1M | $1M | $2M | $1M | $1M | $-365.0K | $415.0K | · | |
| Free Cash Flow | $105M | $157M | $17M | $-114M | $-127M | $-144M | $-152M | $-170M | $-219M | $-212M | $-124M | $-67M |
लाभप्रदता 8
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 94.3% | 98.0% | 97.8% | 97.7% | 96.7% | 94.5% | 92.7% | 82.2% | · | · | |
| Operating Margin | 9.8% | 24.1% | -10.1% | -43.2% | -35.2% | -64.9% | -72.7% | -110.6% | -234.1% | -1574.1% | -269855.7% | -77691.7% | |
| Net Margin | 36.5% | 23.6% | -8.4% | -41.8% | -34.7% | -63.7% | -69.4% | -109.6% | -231.7% | -1565.9% | -269578.7% | -77062.5% | |
| Pretax Margin | 13.0% | 26.9% | -7.0% | -41.3% | -34.6% | -63.6% | -69.1% | -109.0% | -230.8% | -1558.2% | -269037.7% | · | |
| EBITDA Margin | 9.8% | 24.1% | -10.1% | -43.2% | -35.2% | -64.9% | -72.7% | -110.6% | -234.1% | -1574.1% | -269855.7% | -77691.7% | |
| ROA | 28.4% | 23.4% | -9.2% | -33.5% | -22.6% | -36.0% | -35.5% | -53.0% | -61.2% | -69.3% | -60.1% | -35.9% | |
| ROE | 38.1% | 34.6% | -15.4% | -52.3% | -30.3% | -43.9% | -33.9% | -69.8% | -67.8% | -75.6% | -64.6% | -37.6% | |
| ROIC | 24.0% | 27.6% | -20.4% | -56.5% | -31.6% | -45.8% | -35.4% | -51.9% | -87.5% | -52.9% | -82.6% | · |
तरलता और शोधन क्षमता 2
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 2.4 | 2.4 | 4.0 | 6.4 | 6.8 | 10.2 | 8.8 | 7.6 | 12.9 | 10.0 | 20.5 | |
| Quick Ratio | 1.1 | 1.1 | 1.1 | 1.4 | 2.2 | 3.5 | 3.0 | 2.7 | 1.8 | 4.0 | 4.7 | 3.9 |
दक्षता 3
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 1.0 | 1.1 | 0.8 | 0.7 | 0.6 | 0.5 | 0.5 | 0.3 | 0.0 | 0.0 | 0.0 | |
| Inventory Turnover | 0.9 | 1.2 | 1.6 | 0.8 | 0.9 | 1.3 | 2.2 | · | 1.9 | 1.5 | · | · | |
| Receivables Turnover | 9.7 | 9.7 | 9.1 | 8.2 | 8.6 | 10.5 | 11.0 | 10.3 | 10.7 | 5.9 | · | · |
विकास दरें 5
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.9% | 31.9% | 40.5% | 6.8% | 9.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 27.5% | 25.5% | 18.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 19.4% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 69.1% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 72.7% | · | · | · | · | · | · | · | · | · | · | · |
मूल्यांकन (TTM) 10
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.07B | $958M | $726M | $517M | $484M | $442M | $339M | $224M | $125M | $17M | $61.0K | $120.0K | |
| Net Income TTM | $391M | $226M | $-61M | $-216M | $-168M | $-282M | $-235M | $-245M | $-289M | $-271M | $-164M | $-92M | |
| Market Cap | $4.55B | $3.06B | $5.16B | $2.58B | $3.76B | $8.53B | $6.64B | $2.33B | $3.75B | $3.50B | $3.63B | $3.18B | |
| P/E | 11.6 | 13.5 | -84.6 | -11.9 | -22.2 | -29.9 | · | · | · | · | · | · | |
| P/S | 4.2 | 3.2 | 7.1 | 5.0 | 7.8 | 19.3 | 19.6 | 10.4 | 30.0 | 202.0 | 59575.7 | 26470.9 | |
| P/B | 3.7 | 4.2 | 11.9 | 6.4 | 6.9 | 13.6 | 9.5 | 4.9 | 11.2 | 6.8 | 18.2 | 10.3 | |
| P / Tangible Book | 4.1 | 5.0 | 14.1 | 6.4 | 6.9 | 13.6 | · | · | · | · | · | · | |
| P / Cash Flow | 41.4 | 19.4 | 308.7 | -22.6 | -29.9 | -62.7 | -44.0 | -13.9 | -17.2 | -16.6 | -29.8 | -47.8 | |
| P / FCF | 43.3 | 19.5 | 309.6 | -22.6 | -29.6 | -59.4 | -43.6 | -13.7 | -17.1 | -16.5 | -29.3 | -47.7 | |
| Earnings Yield | 8.6% | 7.4% | -1.2% | -8.4% | -4.5% | -3.4% | · | · | · | · | · | · |
आय विवरण 16
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $308M | $268M | $284M | $279M | $265M | $244M | $260M | $250M | $242M | $206M | $231M | $212M | $165M | $118M | $136M | $131M | |
| Cost of Revenue | $28M | $25M | $26M | $22M | $21M | $20M | $22M | $19M | $18M | $23M | $18M | $15M | $7M | $2M | $2M | $2M | |
| Gross Profit | · | · | · | · | · | · | · | · | · | · | $213M | $197M | $158M | $117M | $134M | $129M | |
| R&D Expense | $82M | $77M | $85M | $88M | $78M | $78M | $101M | $67M | $76M | $60M | $67M | $157M | $59M | $69M | $76M | $81M | |
| SG&A Expense | $160M | $171M | $156M | $133M | $134M | $126M | $130M | $133M | $117M | $108M | $111M | $98M | $96M | $101M | $104M | $78M | |
| Operating Expenses | $270M | $273M | $267M | $243M | $232M | $225M | $106M | $219M | $212M | $191M | $196M | $269M | $162M | $172M | $183M | $162M | |
| Operating Income | $38M | $-5M | $17M | $36M | $32M | $19M | $154M | $32M | $30M | $15M | $35M | $-58M | $3M | $-54M | $-46M | $-31M | |
| Other Non-op | $647.0K | $542.0K | $596.0K | $593.0K | $594.0K | $588.0K | $575.0K | $576.0K | $386.0K | $286.0K | $0 | $2M | $-1M | $5M | $2M | $2M | |
| Pretax Income | $46M | $4M | $26M | $45M | $40M | $28M | $161M | $39M | $37M | $21M | $40M | $-52M | $6M | $-45M | $-41M | $-26M | |
| Income Tax | $15M | $344.0K | $-247M | $-27M | $14M | $9M | $17M | $6M | $4M | $4M | $-6M | $13M | $5M | $-2M | $835.0K | $768.0K | |
| Net Income | $32M | $4M | $274M | $72M | $27M | $19M | $144M | $33M | $33M | $17M | $46M | $-65M | $1M | $-43M | $-42M | $-27M | |
| EPS (Basic) | $0.18 | $0.02 | $1.62 | $0.43 | $0.16 | $0.11 | $0.87 | $0.20 | $0.20 | $0.10 | $0.29 | $-0.40 | $0.01 | $-0.27 | $-0.26 | $-0.17 | |
| EPS (Diluted) | $0.18 | $0.02 | $1.61 | $0.42 | $0.16 | $0.11 | $0.86 | $0.20 | $0.20 | $0.10 | $0.29 | $-0.40 | $0.01 | $-0.27 | $-0.26 | $-0.17 | |
| Shares (Basic) | 171,603,000 | 170,517,000 | -335,115,000 | 168,836,000 | 167,827,000 | 166,808,000 | -330,606,000 | 165,974,000 | 165,551,000 | 164,798,000 | -326,136,000 | 164,234,000 | 163,458,000 | 162,263,000 | 128,494 | 161,852 | |
| Shares (Diluted) | 172,851,000 | 172,706,000 | -337,080,000 | 170,650,000 | 168,681,000 | 167,668,000 | -332,613,000 | 166,178,000 | 166,174,000 | 166,623,000 | -327,724,000 | 164,234,000 | 165,046,000 | 162,263,000 | 128,494 | 161,852 | |
| EBITDA | $38M | $-5M | · | $36M | $32M | $19M | · | $32M | $30M | $15M | · | $-58M | $3M | $-54M | · | $-31M |
बैलेंस शीट 24
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $385M | $282M | $178M | $258M | $254M | $218M | $320M | $155M | $177M | $205M | $189M | $98M | $108M | $291M | $115M | $155M | |
| Receivables | $151M | $135M | $121M | $116M | $108M | $106M | $99M | $98M | $104M | $95M | · | $93M | $82M | $66M | · | $56M | |
| Inventory | $109M | $112M | $111M | $106M | $111M | $103M | $92M | $87M | $86M | $67M | · | $25M | $14M | $11M | · | $12M | |
| Prepaid Expense | $69M | $65M | $60M | $61M | $53M | $53M | $56M | $52M | $46M | $43M | · | $38M | $24M | $24M | · | $23M | |
| Current Assets | $1.22B | $1.10B | $1.06B | $1.08B | $961M | $871M | $938M | $788M | $729M | $675M | · | $499M | $493M | $503M | · | $522M | |
| PP&E (Net) | $17M | $15M | $8M | $4M | $4M | $3M | $4M | $4M | $4M | $4M | · | $5M | $5M | $6M | · | $7M | |
| PP&E (Gross) | · | · | $17M | · | · | · | $14M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $9M | · | · | · | $10M | · | · | · | · | · | · | · | · | · | |
| Intangibles | $103M | $106M | $109M | $112M | $114M | $117M | $120M | $106M | $108M | $110M | · | $67M | $68M | $70M | · | · | |
| Other Non-current Assets | $4M | $4M | $4M | $3M | $2M | $1M | $359.0K | $359.0K | $476.0K | $476.0K | · | $475.0K | $11M | $12M | · | $6M | |
| Total Assets | $1.74B | $1.61B | $1.56B | $1.33B | $1.23B | $1.13B | $1.19B | $977M | $914M | $855M | · | $633M | $643M | $655M | · | $602M | |
| Accounts Payable | $45M | $12M | $11M | $22M | $20M | $18M | $16M | $19M | $20M | $19M | · | $12M | $19M | $17M | · | $10M | |
| Accrued Liabilities | $317M | $293M | $266M | $335M | $310M | $284M | $379M | $325M | $318M | $311M | · | $197M | $169M | $207M | · | $107M | |
| Current Liabilities | $361M | $306M | $277M | $357M | $330M | $303M | $395M | $344M | $338M | $331M | · | $210M | $188M | $224M | · | $117M | |
| Capital Leases | $60M | $39M | $41M | $43M | $45M | $45M | $42M | $40M | $47M | $49M | · | $48M | $50M | $51M | · | $54M | |
| Deferred Tax | · | · | $11M | · | · | · | $11M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $15M | $13M | $19M | $14M | $29M | $20M | $18M | $15M | $12M | $11M | · | $13M | $9M | $5M | · | $6M | |
| Total Liabilities | $436M | $357M | $337M | $413M | $403M | $367M | $455M | $400M | $397M | $391M | · | $270M | $247M | $281M | · | $177M | |
| Common Stock | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | · | $16.0K | $16.0K | $16.0K | · | $16.0K | |
| Retained Earnings | $-1.78B | $-1.81B | $-1.81B | $-2.09B | $-2.16B | $-2.19B | $-2.20B | $-2.35B | $-2.38B | $-2.41B | · | $-2.48B | $-2.41B | $-2.41B | · | $-2.33B | |
| AOCI | $-958.0K | $-563.0K | $1M | $989.0K | $406.0K | $437.0K | $292.0K | $858.0K | $-339.0K | $-229.0K | · | $-319.0K | $-535.0K | $-220.0K | · | $-1M | |
| Stockholders' Equity | $1.31B | $1.25B | $1.23B | $917M | $822M | $765M | $733M | $577M | $517M | $464M | $432M | $362M | $396M | $374M | $400M | $426M | |
| Liabilities + Equity | $1.74B | $1.61B | $1.56B | $1.33B | $1.23B | $1.13B | $1.19B | $977M | $914M | $855M | · | $633M | $643M | $655M | · | $602M | |
| Shares Outstanding | 172,132,442 | 171,086,205 | 170,309,376 | 169,146,043 | 168,607,881 | 167,116,045 | 166,708,856 | 166,351,715 | 165,853,301 | 164,959,736 | · | 163,968,949 | 163,355,787 | 162,384,178 | · | 161,871,806 |
नकदी प्रवाह 10
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $17M | $15M | $13M | $13M | $14M | $11M | $10M | $26M | $16M | $15M | $18M | $19M | $15M | $15M | $14M | $18M | |
| Amort. of Intangibles | $3M | $3M | $3M | $3M | $3M | $3M | $5M | $2M | $2M | $5M | $1M | $1M | $1M | $0 | $0 | $0 | |
| Operating Cash Flow | $101M | $34M | $-49M | $74M | $64M | $20M | $40M | $63M | $25M | $29M | $85M | $-59M | $8M | $-18M | $-24M | $-727.0K | |
| CapEx | $5M | $5M | $4M | $388.0K | $297.0K | $0 | $453.0K | $70.0K | · | · | $0 | · | · | · | $0 | $0 | |
| Investing Cash Flow | $-9M | $66M | $-56M | $-79M | $-43M | $-124M | $122M | $-82M | $-56M | $-14M | $-347.0K | $34M | $-194M | $193M | $-18M | $15M | |
| Stock Issued | $10M | $4M | $23M | $9M | $16M | $2M | $2M | $268.0K | $4M | $1M | $5M | $13M | $5M | $1M | $2M | $287.0K | |
| Net Stock Activity | · | $4M | · | · | · | $2M | · | · | · | $1M | · | · | · | $1M | · | · | |
| Financing Cash Flow | $10M | $4M | $23M | $9M | $16M | $2M | $2M | $268.0K | $4M | $1M | $5M | $13M | $5M | $1M | $2M | $287.0K | |
| Net Change in Cash | $103M | $105M | $-82M | $4M | $37M | $-102M | $164M | $-19M | $-28M | $16M | $90M | $-12M | $-181M | $176M | $-40M | $15M | |
| Free Cash Flow | · | $29M | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
लाभप्रदता 7
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 12.3% | -1.7% | · | 12.8% | 12.2% | 7.9% | · | 12.6% | 12.6% | 7.4% | · | -27.3% | 1.8% | -45.2% | · | -23.6% | |
| Net Margin | 10.2% | 1.4% | · | 25.8% | 10.1% | 7.8% | · | 13.1% | 13.8% | 8.0% | · | -30.8% | 0.67% | -36.3% | · | -20.8% | |
| Pretax Margin | 15.1% | 1.5% | · | 16.0% | 15.2% | 11.4% | · | 15.5% | 15.4% | 10.2% | · | -24.6% | 3.8% | -37.9% | · | -20.2% | |
| EBITDA Margin | 12.3% | -1.7% | · | 12.8% | 12.2% | 7.9% | · | 12.6% | 12.6% | 7.4% | · | -27.3% | 1.8% | -45.2% | · | -23.6% | |
| ROA | 2.1% | 0.27% | · | 6.2% | 2.5% | 1.9% | · | 4.1% | 4.3% | 2.2% | · | -10.5% | 0.18% | -6.7% | · | -4.1% | |
| ROE | 3.0% | 0.36% | · | 9.6% | 4.0% | 3.1% | · | 7.0% | 7.3% | 4.0% | · | -16.6% | 0.27% | -10.5% | · | -5.5% | |
| ROIC | 2.0% | -0.34% | · | 6.3% | 2.6% | 1.7% | · | 4.6% | 5.3% | 2.6% | · | -19.9% | 0.13% | -13.7% | · | -7.5% |
तरलता और शोधन क्षमता 2
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | 3.6 | · | 3.0 | 2.9 | 2.9 | · | 2.3 | 2.2 | 2.0 | · | 2.4 | 2.6 | 2.2 | · | 4.5 | |
| Quick Ratio | 1.5 | 1.4 | · | 1.0 | 1.1 | 1.1 | · | 0.7 | 0.8 | 0.9 | · | 0.9 | 1.0 | 1.6 | · | 1.8 |
दक्षता 3
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.2 | · | 0.2 | |
| Inventory Turnover | 0.3 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.4 | 0.6 | · | 0.8 | 0.6 | 0.1 | · | 0.2 | |
| Receivables Turnover | 2.4 | 2.2 | · | 2.6 | 2.5 | 2.4 | · | 2.6 | 2.6 | 2.6 | · | 2.9 | 2.2 | 1.8 | · | 2.2 |
मूल्यांकन (TTM) 10
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.12B | $1.06B | · | $1.04B | $1.00B | $943M | · | $929M | $891M | $814M | · | $632M | $551M | $520M | · | $512M | |
| Net Income TTM | $134M | $121M | · | $150M | $112M | $102M | · | $129M | $31M | $-2M | · | $-149M | $-111M | $-146M | · | $-217M | |
| Market Cap | $4.35B | $3.81B | · | $3.61B | $3.64B | $2.78B | · | $2.56B | $2.70B | $3.05B | · | $3.42B | $3.91B | $3.06B | · | $2.65B | |
| P/E | 32.4 | 31.4 | · | 24.0 | 32.2 | 27.2 | · | 19.7 | 90.3 | -1849.0 | · | -22.7 | -34.7 | -20.7 | · | -12.1 | |
| P/S | 3.9 | 3.6 | · | 3.5 | 3.6 | 2.9 | · | 2.8 | 3.0 | 3.7 | · | 5.4 | 7.1 | 5.9 | · | 5.2 | |
| P/B | 3.3 | 3.1 | · | 3.9 | 4.4 | 3.6 | · | 4.4 | 5.2 | 6.6 | · | 9.4 | 9.9 | 8.2 | · | 6.2 | |
| P / Tangible Book | 3.6 | 3.3 | · | 4.5 | 5.1 | 4.3 | · | 5.4 | 6.6 | 8.6 | · | 11.6 | 11.9 | 10.0 | · | 6.2 | |
| P / Cash Flow | · | 112.1 | · | · | · | 136.6 | · | · | · | 104.9 | · | · | · | -170.4 | · | · | |
| P / FCF | · | 132.4 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | 3.1% | 3.2% | · | 4.2% | 3.1% | 3.7% | · | 5.1% | 1.1% | -0.05% | · | -4.4% | -2.9% | -4.8% | · | -8.2% |
वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष
आय विवरण
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| राजस्व | $1.07B | $958M | $726M | $517M | $484M |
| सकल मार्जिन % | — | — | 94.3% | 98.0% | 97.8% |
| परिचालन मार्जिन % | 9.8% | 24.1% | -10.1% | -43.2% | -35.2% |
| शुद्ध आय | $391M | $226M | $-61M | $-216M | $-168M |
| तनुकरणित EPS | $2.30 | $1.36 | $-0.37 | $-1.34 | $-1.05 |
बैलेंस शीट
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| वर्तमान अनुपात | 3.8 | 2.4 | 2.4 | 4.0 | 6.4 |
| त्वरित अनुपात | 1.1 | 1.1 | 1.1 | 1.4 | 2.2 |
नकदी प्रवाह
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| फ्री कैश फ्लो | $105M | $157M | $17M | $-114M | $-127M |
ताज़ा समाचार इस कंपनी का उल्लेख करने वाली हालिया सुर्खियां
ट्रेडिंग सिग्नल प्रवेश मूल्य और जोखिम/इनाम अनुपात के साथ हालिया खरीद/बिक्री संकेत
मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ
उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर पूर्ण फंडामेंटल में किसी भी पंक्ति के बगल में ➕ पर क्लिक करें।
आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।
संस्थागत मालिक (13F) 387 फाइलर्स · $3.2B कुल · तिथि अनुसार 30 जून 2026
संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।
| नई स्थितियाँ | बाहर निकली पोजीशन | बढ़ाया | घटा हुआ | शुद्ध शेयर परिवर्तन |
|---|---|---|---|---|
| 56 (+10 पिछली तिमाही की तुलना में) | 37 (+10 पिछली तिमाही की तुलना में) | 136 (+11 पिछली तिमाही की तुलना में) | 100 (-13 पिछली तिमाही की तुलना में) | +17.3M |
Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।
| संस्था | मूल्य | शेयर | % ट्रैक किए गए 13F का | प्रकार |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | $1085696471 | 42912904 | 33.44% | शेयर |
| STATE STREET CORP | $229628164 | 9076212 | 7.07% | शेयर |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $223612785 | 8838450 | 6.89% | शेयर |
| RTW INVESTMENTS, LP | $180756457 | 7144524 | 5.57% | शेयर |
| VANGUARD CAPITAL MANAGEMENT LLC | $145822875 | 5763750 | 4.49% | शेयर |
| DIMENSIONAL FUND ADVISORS LP | $88971384 | 3516656 | 2.74% | शेयर |
| GEODE CAPITAL MANAGEMENT, LLC | $73088127 | 2888204 | 2.25% | शेयर |
| Qube Research & Technologies Ltd | $61899233 | 2446610 | 1.91% | शेयर |
| Point72 Asset Management, L.P. | $61559150 | 2433168 | 1.90% | शेयर |
| CITADEL ADVISORS LLC | $53414195 | 2111233 | 1.65% | शेयर |
| Pictet Asset Management Holding SA | $50146450 | 1983198 | 1.54% | शेयर |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $49826959 | 1969445 | 1.53% | शेयर |
| MARSHALL WACE, LLP | $44649289 | 1764794 | 1.38% | शेयर |
| BRAIDWELL LP | $41653895 | 1646399 | 1.28% | शेयर |
| NORGES BANK | $41069692 | 1623308 | 1.26% | शेयर |
| Frazier Life Sciences Management, L.P. | $36386409 | 1438198 | 1.12% | शेयर |
| Artisan Partners Limited Partnership | $33525890 | 1325134 | 1.03% | शेयर |
| RENAISSANCE TECHNOLOGIES LLC | $32449679 | 1282596 | 1.00% | शेयर |
| GOLDMAN SACHS GROUP INC | $32070584 | 1267612 | 0.99% | शेयर |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $30520301 | 1206336 | 0.94% | शेयर |
| D. E. Shaw & Co., Inc. | $28330257 | 1119773 | 0.87% | शेयर |
| Allspring Global Investments Holdings, LLC | $26143513 | 1037441 | 0.81% | शेयर |
| TWO SIGMA INVESTMENTS, LP | $23452898 | 926992 | 0.72% | शेयर |
| VANGUARD FIDUCIARY TRUST CO | $23082961 | 912370 | 0.71% | शेयर |
| BANK OF AMERICA CORP /DE/ | $21702062 | 857789 | 0.67% | शेयर |
| PANAGORA ASSET MANAGEMENT INC | $17985922 | 710906 | 0.55% | शेयर |
| Fisher Asset Management, LLC | $17690535 | 699230 | 0.54% | शेयर |
| Allianz Asset Management GmbH | $15730341 | 706664 | 0.48% | शेयर |
| RICE HALL JAMES & ASSOCIATES, LLC | $15657841 | 618887 | 0.48% | शेयर |
| MILLENNIUM MANAGEMENT LLC | $14925077 | 589924 | 0.46% | शेयर |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $14771456 | 583852 | 0.45% | शेयर |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $12903000 | 510000 | 0.40% | शेयर |
| Hudson Bay Capital Management LP | $11764500 | 465000 | 0.36% | शेयर |
| GLENMEDE TRUST CO NA | $11656544 | 460733 | 0.36% | शेयर |
| JUPITER ASSET MANAGEMENT LTD | $11599190 | 458466 | 0.36% | शेयर |
| Public Sector Pension Investment Board | $11014988 | 435375 | 0.34% | शेयर |
| MACKENZIE FINANCIAL CORP | $10646872 | 420825 | 0.33% | शेयर |
| Ishara Investments LP | $10373000 | 410000 | 0.32% | शेयर |
| TWO SIGMA ADVISERS, LP | $9888042 | 370200 | 0.30% | शेयर |
| Balyasny Asset Management L.P. | $9817007 | 388024 | 0.30% | शेयर |
| BlackRock, Inc. | $9281482 | 366857 | 0.29% | शेयर |
| SPHERA FUNDS MANAGEMENT LTD. | $9020310 | 356534 | 0.28% | शेयर |
| AMERIPRISE FINANCIAL INC | $8039177 | 317754 | 0.25% | शेयर |
| PRUDENTIAL FINANCIAL INC | $7985313 | 315625 | 0.25% | शेयर |
| Alyeska Investment Group, L.P. | $7850261 | 310287 | 0.24% | शेयर |
| RHUMBLINE ADVISERS | $7663389 | 302902 | 0.24% | शेयर |
| Schonfeld Strategic Advisors LLC | $7189171 | 284157 | 0.22% | शेयर |
| Edgestream Partners, L.P. | $7167515 | 283301 | 0.22% | शेयर |
| Logos Global Management LP | $6325000 | 250000 | 0.19% | शेयर |
| LAZARD ASSET MANAGEMENT LLC | $6263496 | 247569 | 0.19% | शेयर |
| FMR LLC | $6052317 | 239222 | 0.19% | शेयर |
| Swiss National Bank | $5841871 | 230904 | 0.18% | शेयर |
| VICTORY CAPITAL MANAGEMENT INC | $5432213 | 214712 | 0.17% | शेयर |
| ALPS ADVISORS INC | $4985340 | 197049 | 0.15% | शेयर |
| ENVESTNET ASSET MANAGEMENT INC | $4926239 | 194713 | 0.15% | शेयर |
| Legal & General Group Plc | $4918245 | 194397 | 0.15% | शेयर |
| FIRST TRUST ADVISORS LP | $4664965 | 184386 | 0.14% | शेयर |
| NEW YORK STATE COMMON RETIREMENT FUND | $4364807 | 172522 | 0.13% | शेयर |
| Birchview Capital, LP | $4326300 | 171000 | 0.13% | शेयर |
| MARTINGALE ASSET MANAGEMENT L P | $4247693 | 167893 | 0.13% | शेयर |
| Tetragon Partners GP Ltd | $4247238 | 167875 | 0.13% | शेयर |
| GREAT LAKES ADVISORS, LLC | $3822526 | 151088 | 0.12% | शेयर |
| AMERICAN CENTURY COMPANIES INC | $3635306 | 143688 | 0.11% | शेयर |
| STEMPOINT CAPITAL LP | $3622125 | 143167 | 0.11% | शेयर |
| ALLIANCEBERNSTEIN L.P. | $3585329 | 161066 | 0.11% | शेयर |
| Squarepoint Ops LLC | $3542329 | 140013 | 0.11% | शेयर |
| ORBIMED ADVISORS LLC | $3466100 | 137000 | 0.11% | शेयर |
| Erste Asset Management GmbH | $3369240 | 133700 | 0.10% | शेयर |
| Emerald Investment Advisers, LLC | $3333326 | 131752 | 0.10% | शेयर |
| Caption Management, LLC | $3289000 | 130000 | 0.10% | पुट ऑप्शन |
| VANGUARD ASSET MANAGEMENT, Ltd | $3130217 | 123724 | 0.10% | शेयर |
| WELLS FARGO & COMPANY/MN | $3084475 | 121916 | 0.09% | शेयर |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $3077311 | 138244 | 0.09% | शेयर |
| Longaeva Partners L.P. | $2968145 | 117318 | 0.09% | शेयर |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $2948791 | 116553 | 0.09% | शेयर |
| Trexquant Investment LP | $2935357 | 116022 | 0.09% | शेयर |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $2909778 | 115011 | 0.09% | शेयर |
| JONES FINANCIAL COMPANIES LLLP | $2868477 | 113289 | 0.09% | शेयर |
| Rafferty Asset Management, LLC | $2789426 | 110254 | 0.09% | शेयर |
| Nan Fung Group Holdings Ltd | $2605495 | 102984 | 0.08% | शेयर |
| RAYMOND JAMES FINANCIAL INC | $2406232 | 95108 | 0.07% | शेयर |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $2344000 | 92648 | 0.07% | शेयर |
| ROYCE & ASSOCIATES LP | $2324691 | 91885 | 0.07% | शेयर |
| HOHIMER WEALTH MANAGEMENT, LLC | $2322540 | 91800 | 0.07% | शेयर |
| Point72 Europe (London) LLP | $2305047 | 108015 | 0.07% | शेयर |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $2134076 | 79898 | 0.07% | शेयर |
| Campbell & CO Investment Adviser LLC | $2108527 | 83341 | 0.06% | शेयर |
| Verdad Advisers, LP | $2090514 | 82629 | 0.06% | शेयर |
| VOYA INVESTMENT MANAGEMENT LLC | $2072576 | 81920 | 0.06% | शेयर |
| CITADEL ADVISORS LLC | $2049300 | 81000 | 0.06% | कॉल ऑप्शन |
| GUGGENHEIM CAPITAL LLC | $1979776 | 78252 | 0.06% | शेयर |
| WESBANCO BANK INC | $1978460 | 78200 | 0.06% | शेयर |
| Phocas Financial Corp. | $1954299 | 77245 | 0.06% | शेयर |
| MetLife Investment Management, LLC | $1899043 | 75061 | 0.06% | शेयर |
| STATE OF WISCONSIN INVESTMENT BOARD | $1850493 | 73142 | 0.06% | शेयर |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1788331 | 70685 | 0.06% | शेयर |
| Freestone Grove Partners LP | $1755643 | 69393 | 0.05% | शेयर |
| CenterBook Partners LP | $1743878 | 68928 | 0.05% | शेयर |
| CANADA PENSION PLAN INVESTMENT BOARD | $1722930 | 68100 | 0.05% | शेयर |
| Illinois Municipal Retirement Fund | $1693380 | 66932 | 0.05% | शेयर |
कंपनी के अंदरूनी सूत्र 37 इनसाइडर्स · 19 अधिकारी · 19 निदेशक
| अंदरूनी | भूमिका | अंतिम गतिविधि | शेयरों का स्वामित्व | खरीद 12m | बिक्री 12m | नेट 12m |
|---|---|---|---|---|---|---|
| Stephen Davis | CEO | 6 जनवरी 2024 M | 96521 | 0 | 0 | $0 |
| Uli Hacksell | CEO | 25 मार्च 2011 A | 69916 | 0 | 0 | $0 |
| Elena Ridloff | EVP and CFO | 29 अप्रैल 2021 M | 10553 | 0 | 0 | $0 |
| Todd S. Young | EVP AND CFO | 15 अक्टूबर 2018 A | — | 0 | 0 | $0 |
| Thomas H Aasen | Exec. VP, CFO & CBO | 25 मार्च 2011 A | 13899 | 0 | 0 | $0 |
| Srdjan R. Stankovic | President | 21 नवमबर 2022 M | 61234 | 0 | 0 | $0 |
| Mark R Brann | President & CSO | 16 जून 2006 S | 317756 | 0 | 0 | $0 |
| Brendan Teehan | EVP, COO, Head of Commercial | 6 जनवरी 2024 M | 30949 | 0 | 0 | $0 |
| Elizabeth H.Z. Thompson | EVP, Head of Research & Dev | 29 जुलाई 2026 M | 18994 | 0 | 2 | $-432662 |
| James Kihara | PRINCIPAL ACCOUNTING OFFICER | 26 जून 2026 S | 13088 | 0 | 2 | $-412253 |
| Austin D. Kim | EVP,General Counsel, Secretary | 6 जनवरी 2024 M | 46901 | 0 | 0 | $0 |
| Douglas J Williamson | Executive VP, Research & Dev | 10 फ़रवरी 2023 A | — | 0 | 0 | $0 |
| Michael J. Yang | EVP and CCO | 6 जनवरी 2021 M | 8059 | 0 | 0 | $0 |
| Eric Alejandro Miller | Controller & PAO | 15 अक्टूबर 2019 M | 270 | 0 | 0 | $0 |
| Glenn Baity | VP, GC & Sec. | 25 मार्च 2011 A | — | 0 | 0 | $0 |
| Roger Mills | Executive VP, Development | 25 मार्च 2011 A | — | 0 | 0 | $0 |
| Bo-Ragnar Tolf | VP/Mg. Dir. ACADIA Pharma AB | 8 जुलाई 2009 M | 20000 | 0 | 0 | $0 |
| Brian Lundstrom | Sr. VP, Bus. Development | 7 मार्च 2008 A | 0 | 0 | 0 | $0 |
| Robert E Davis | Exec. VP, Drug Discovery | 11 मार्च 2005 A | — | 0 | 0 | $0 |
| Adora Ndu | निदेशक | 29 मई 2026 A | 32908 | 0 | 0 | $0 |
| Elizabeth A. Garofalo | निदेशक | 29 मई 2026 A | 33489 | 0 | 0 | $0 |
| Jonathan Poole | निदेशक | 29 मई 2026 A | 2010 | 0 | 0 | $0 |
| James M Daly | निदेशक | 29 मई 2026 A | 12148 | 0 | 0 | $0 |
| Laura Brege | निदेशक | 29 मई 2026 A | 23202 | 0 | 0 | $0 |
| Edmund Harrigan | निदेशक | 29 मई 2026 A | 43148 | 0 | 0 | $0 |
| Daniel B Soland | निदेशक | 1 जून 2023 A | 28002 | 0 | 0 | $0 |
| Torsten Rasmussen | निदेशक | 11 जून 2010 A | 4000 | 0 | 0 | $0 |
| Leslie L Iversen | निदेशक | 11 जून 2010 A | 9000 | 0 | 0 | $0 |
| Mary Ann Gray | निदेशक | 11 जून 2010 A | — | 0 | 0 | $0 |
| Michael T Borer | निदेशक | 11 जून 2010 A | — | 0 | 0 | $0 |
| Lester J Ph D Kaplan | निदेशक | 11 जून 2010 A | 4000 | 0 | 0 | $0 |
| Gordon M Binder | निदेशक | 12 जून 2009 A | 14364 | 0 | 0 | $0 |
| Alan G Walton | निदेशक | 12 जून 2009 A | 25979 | 0 | 0 | $0 |
| Martien Van Osch | निदेशक | 10 जून 2005 A | 1168892 | 0 | 0 | $0 |
| GORDON CARL L | निदेशक | 20 अप्रैल 2005 A | 774006 | 0 | 0 | $0 |
| Mark C. Schneyer | — | 6 अगस्त 2026 M | 67828 | 0 | 3 | $-587248 |
| John Joseph Kaiser | — | 20 अक्टूबर 2008 A | — | 0 | 0 | $0 |
SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S
कार्यकर्ता और 5%+ मालिक 6 होल्डिंग्स
जिन निवेशकों ने SEC शेड्यूल 13D दाखिल किया है — जारीकर्ता को प्रभावित करने के इरादे से 5% से अधिक लाभकारी स्वामित्व (कार्यकर्ता दांव, बोर्ड अभियान, M&A)। प्रत्येक पंक्ति उस फाइलर की स्थिति की सबसे हालिया ज्ञात स्थिति दिखाती है।
| फाइलर | दाखिल किया | दांव | स्थिति | उद्देश्य | फाइलिंग |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker, FBB3 LLC ×14 फाइलिंग | 26 फ़रवरी 2026 | 25.40% | संशोधन | — | SEC |
| Baker Bros. Advisors, LLC, Felix J. Baker, Julian C. Baker ×4 फाइलिंग | 6 जून 2013 | — | प्रारंभिक फाइलिंग | — | SEC |
| अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति | 2 मई 2005 | — | प्रारंभिक फाइलिंग | — | SEC |
| अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति | 2 मई 2005 | — | प्रारंभिक फाइलिंग | — | SEC |
| अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति, अघोषित रिपोर्टिंग व्यक्ति | 2 मई 2005 | — | प्रारंभिक फाइलिंग | — | SEC |
| Oxford Bioscience Partners IV L.P., mRNA Fund II L.P., OBP Management IV L.P., Jeffrey T. Barnes, Mark P. Carthy, Jonathan J. Fleming, Michael E. Lytton, Alan G. Walton | 29 अप्रैल 2005 | — | प्रारंभिक फाइलिंग | निष्क्रिय निवेश | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ईटीएफ स्वामित्व 77 ETFs द्वारा धारित
वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।
| फंड | भार | इकाइयाँ | तिथि अनुसार | स्रोत |
|---|---|---|---|---|
| IBRN · iShares Trust | 4.89% | 13265 SH | 8 अगस्त 2026 | दैनिक |
| PBE · Invesco Exchange-Traded Fund Trust | 3.29% | 407914 SH | 8 अगस्त 2026 | दैनिक |
| SBIO · ALPS ETF Trust | 2.35% | 175740 NS | 31 मई 2026 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 1.87% | 109972 SH | 8 अगस्त 2026 | दैनिक |
| BBP · ETFis Series Trust I | 1.32% | 34855 NS | 30 अप्रैल 2026 | N-PORT |
| RZG · Invesco Exchange-Traded Fund Trust | 1.25% | 59514 SH | 8 अगस्त 2026 | दैनिक |
| LABU · Direxion Shares ETF Trust | 0.85% | 195542 NS | 30 अप्रैल 2026 | N-PORT |
| ROSC · Lattice Strategies Trust | 0.56% | 13607 NS | 30 अप्रैल 2026 | N-PORT |
| IJT · iShares Trust | 0.40% | 1176933 SH | 8 अगस्त 2026 | दैनिक |
| OASC · Unified Series Trust | 0.39% | 15269 NS | 31 मई 2026 | N-PORT |
| IBB · iShares Trust | 0.37% | 1239145 SH | 8 अगस्त 2026 | दैनिक |
| VIOG · VANGUARD ADMIRAL FUNDS | 0.35% | 150827 SH | 8 अगस्त 2026 | दैनिक |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.34% | 9317 SH | 8 अगस्त 2026 | दैनिक |
| FNY · First Trust Exchange-Traded AlphaDE… | 0.27% | 61606 NS | 30 अप्रैल 2026 | N-PORT |
| BFOR · ALPS ETF Trust | 0.24% | 24003 NS | 31 मई 2026 | N-PORT |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0.23% | 20369 SH | 8 अगस्त 2026 | दैनिक |
| IWO · iShares Trust | 0.23% | 1166817 SH | 8 अगस्त 2026 | दैनिक |
| XJR · iShares Trust | 0.23% | 14974 SH | 8 अगस्त 2026 | दैनिक |
| GSSC · Goldman Sachs ETF Trust | 0.20% | 89945 NS | 31 मई 2026 | N-PORT |
| IJR · iShares Trust | 0.20% | 7728433 SH | 8 अगस्त 2026 | दैनिक |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.19% | 137860 SH | 8 अगस्त 2026 | दैनिक |
| BIB · ProShares Trust | 0.19% | 6303 NS | 31 मई 2026 | N-PORT |
| VIOO · VANGUARD ADMIRAL FUNDS | 0.17% | 443221 SH | 8 अगस्त 2026 | दैनिक |
| BKSE · BNY Mellon ETF Trust | 0.17% | 6035 NS | 30 अप्रैल 2026 | N-PORT |
| SMMV · iShares Trust | 0.17% | 17063 SH | 8 अगस्त 2026 | दैनिक |
| SMLF · iShares Trust | 0.15% | 219745 SH | 8 अगस्त 2026 | दैनिक |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0.15% | 47683 NS | 30 अप्रैल 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.14% | 137072 SH | 8 अगस्त 2026 | दैनिक |
| FNX · First Trust Exchange-Traded AlphaDE… | 0.14% | 81552 NS | 30 अप्रैल 2026 | N-PORT |
| SAA · ProShares Trust | 0.12% | 1498 NS | 31 मई 2026 | N-PORT |
| IWM · iShares Trust | 0.12% | 3281125 SH | 8 अगस्त 2026 | दैनिक |
| ISCG · iShares Trust | 0.11% | 39884 SH | 8 अगस्त 2026 | दैनिक |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.10% | 741237 SH | 8 अगस्त 2026 | दैनिक |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0.09% | 66331 SH | 8 अगस्त 2026 | दैनिक |
| VBK · VANGUARD INDEX FUNDS | 0.09% | 1699377 SH | 8 अगस्त 2026 | दैनिक |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.09% | 115210 NS | 31 मई 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.08% | 526641 NS | 30 अप्रैल 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.08% | 16957 NS | 30 अप्रैल 2026 | N-PORT |
| ITWO · ProShares Trust | 0.07% | 5921 NS | 31 मई 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.06% | 599784 NS | 31 मई 2026 | N-PORT |
| ISCB · iShares Trust | 0.06% | 5636 SH | 8 अगस्त 2026 | दैनिक |
| FHLC · FIDELITY COVINGTON TRUST | 0.04% | 54956 NS | 30 अप्रैल 2026 | N-PORT |
| IEUS · iShares Trust | 0.04% | 7411 SH | 8 अगस्त 2026 | दैनिक |
| SMDX · Tidal Trust III | 0.04% | 2306 NS | 30 अप्रैल 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.04% | 4033 SH | 8 अगस्त 2026 | दैनिक |
| UWM · ProShares Trust | 0.04% | 4631 NS | 31 मई 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.04% | 1457036 SH | 8 अगस्त 2026 | दैनिक |
| VB · VANGUARD INDEX FUNDS | 0.04% | 2944095 SH | 8 अगस्त 2026 | दैनिक |
| PDN · Invesco Exchange-Traded Fund Trust … | 0.04% | 14209 SH | 8 अगस्त 2026 | दैनिक |
| VHT · VANGUARD WORLD FUND | 0.04% | 346329 SH | 8 अगस्त 2026 | दैनिक |